City of Cincinnati Intervention Assessment

Instructions: Use the pencil icon in the top right to edit the form below. ↗️ Remember to push PUBLISH when you are done to save your work.

Important Health Center Context Fill out this section during your planning process
Internal Characteristics
What are the characteristics of your health center? (rural/urban; other demographic variables, use of expanded care team, culture)?	Urban FQHC that serves over 40,000 patients annually. Last year 56% of pts were black/AA and 28% reported being Hispanic. Use expanded care team. Our organization engages in ongoing QI work to ensure quality, safety, and value for our patients, and we have an organizational commitment to QI capacity.
How do interventions and/or workflows need to be adapted to ensure health equity?	For the purposes of this project, we continue to utilize the patient details list to determine / drive how we are implementing and delivering our interventions. This is to ensure that we are targeting our AA patient population and improving health equity in our health centers.
How complex are the patient interventions to implement (e.g., perceived difficulty of implementation, reflected by duration, scope, radicalness, disruptiveness, and number of steps required)?	The interventions we have selected are: to continue to use the patient detail list to target (no therapy, active patients, uncontrolled HTN) to message utilizing our WELL bidirectional software to encourage patients to see their PCP and/or the clinical pharmacy team (data-driven patient outreach) we are continuing to assist patients with obtaining validated, automated home BP measurement devices with appropriately-sized upper arm cuffs to improve patient engagement The interventions are not super complex because we are able to use the patient detail list as well as some in-house data to drive these interventions. Additionally, we have already established the protocols for ordering a BP cuff for our patients directly through the pharmacy. So the amount of steps and disruptiveness for these interventions is reduced.
What are key characteristics of the participating setting(s)?	Urban FQHC that serves over 40,000 patients annually. Last year 56% of pts were black/AA and 28% reported being Hispanic. Use expanded care team. Our organization engages in ongoing QI work to ensure quality, safety, and value for our patients, and we have an organizational commitment to QI capacity.
External Characteristics
What external or environmental supports or threats are there?	Some of the identified external or environmental threats are difficulties experienced with our patients in regards to transportation & ability to pay.

Treatment Intensification (Combination Therapy)

Plan

Treatment Intensification (Combination Therapy)

Actual

Describe Intervention

(Select ONE; use BPAA Project Roadmap for ideas on evidence-based strategies)

Chosen intervention: Using WELL to decrease no therapy -> 36 patients needs addressed through utilization of list/data/WELL combo

Plan for intervention:

Chosen Intervention:

Date when implemented:

Updates:

Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention)

Reach of implementers/providers?

Planned:

Reach of implementers/providers?

Actual:

Reach of patients (# of patients receiving treatment intensification)?

Planned:

# AA pts. w/uncontrolled HTN on no therapy (as of 6/30/2023):
# AA pts. w/uncontrolled HTN on monotherapy (as of 6/30/2023):

Reach of patients (# of patients receiving treatment intensification)?

Actual:

Efficacy (Impact of intervention on important outcomes)

How will you measure that your intervention is working? Using WELL to decrease no therapy -> look at % of patients who were on therapy 6 months after each of the text messages are sent

Were you able to accurately measure how your intervention was working?

What outcomes do you expect?

What outcomes have you seen?

How will you ensure your intervention will be effective for your target population?

Did your intervention reach the target population?

What unintended consequences or outcomes might there be?

What unintended outcomes did you experience?

Adoption (#/% and representativeness of staff and sites who implemented the intervention)

How did clinicians respond to interventions to intensify medication more rapidly/address therapeutic inertia?

Who will deliver the intervention (actually do the work)? Include staff and sites, if applicable.

Who delivered the intervention? Did they have the skills and time needed to complete the intervention?

How will you know if clinicians/care teams/sites used the intervention?

What proportion of the planned staff/sites implemented the intervention?

Were there any differences between care teams/sites who adopted the intervention best vs. others who did not (e.g., differences in staff types, capacity, etc.)?

Implementation Fidelity (How closely the staff/sites followed the intervention design, delivered it as intended – also called fidelity to the intervention)

How will you know what adaptations or modifications were made during the intervention?

How did you track modifications during the intervention?

What might be some of the possible obstacles to consistent implementation?

What were the barriers to consistent intervention implementation?

What costs and resources (including time and burden, not just money) need to be considered?

How closely did the staff/sites follow the intervention design and deliver as intended?

Check all that apply:

Followed as designed
Followed with minor modifications
Followed somewhat as designed
Not followed as design
Delivered consistently/as intended
Delivered somewhat consistently/somewhat as intended
Delivered inconsistently/not as intended

Modifications made and other notes:

Maintenance (Extent to which intervention is part of routine practices and protocols)

What reinforcements will you put in place to sustain the intervention, if effective?

Protocols
Clinical decision support (alerts, order sets, templates, registries)
Policies
Regular training
Regular reports
Incentives
Other:

Explain:

What reinforcements did you put into place to sustain the intervention?

Protocols
Clinical decision support (alerts, order sets, templates, registries)
Policies
Regular training
Regular reports
Incentives
Other:

Explain:

How will you spread your intervention and lessons learned?

How will you spread your intervention and lessons learned?

What are likely modifications or adaptations that will need to be made to sustain the intervention over time (e.g., lower cost, different staff, reduced intensity, different settings)?

Intervention #2

Plan

Intervention #2

Actual

Describe Intervention

(Select ONE; use BPAA Project Roadmap for ideas on evidence-based strategies)

Chosen intervention:

Plan for intervention:

Chosen Intervention: Assisting patients with BP cuffs -> 150 patients

Date when implemented:

Updates:

Reach (#/% patients – or providers, for provider-facing interventions – who participated in intervention)

Reach of implementers/providers?

Planned:

Reach of implementers/providers?

Actual:

Reach of patients (# of patients receiving treatment intensification)?

Planned:

# AA pts. w/uncontrolled HTN on no therapy (as of 6/30/2023):
# AA pts. w/uncontrolled HTN on monotherapy (as of 6/30/2023):

Reach of patients (# of patients receiving treatment intensification)?

Actual:

Efficacy (Impact of intervention on important outcomes)

How will you measure that your intervention is working?

Were you able to accurately measure how your intervention was working? Assisting patients with BP cuffs -> Number of blood pressure cuffs dispensed to our project population through the pharmacy